Contineum Therapeutics Inc (CTNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||
| Net Income | -4,824 | -24,253 |
| Depreciation Amortization | 99 | 483 |
| Accounts payable and accrued liabilities | 282 | N/A |
| Other Working Capital | -1,014 | -1,267 |
| Other Operating Activity | 213 | 4,916 |
| Operating Cash Flow | $-5,244 | $-20,121 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 9,407 | N/A |
| PPE Investments | -52 | -118 |
| Other Investing Activity | 0 | 22,417 |
| Investing Cash Flow | $9,355 | $22,299 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -625 | N/A |
| Common Stock Issued | 8 | N/A |
| Other Financing Activity | 0 | -1,239 |
| Financing Cash Flow | $-617 | $-1,239 |
| Beginning Cash Position | 5,569 | 4,630 |
| End Cash Position | 9,063 | 5,569 |
| Net Cash Flow | $3,494 | $939 |
| Free Cash Flow | ||
| Operating Cash Flow | -5,244 | -20,121 |
| Capital Expenditure | -52 | N/A |
| Free Cash Flow | -5,296 | -20,121 |